ARIAD Pharmaceuticals

Ariad Announces FDA Has Given Clearance To Begin Clinical Development Trial

GNC, Southern Copper And Others Insiders Have Been Buying

Top Trending Tickers On StockTwits For February 25

GNC, Southern Copper And Others Insiders Have Been Buying

Top Trending Tickers On StockTwits For February 25

Biotech And Natural Gas ETFs On A Roll

Market Wrap For January 17: Stocks Finish Week With Mixed Results

Biotech And Natural Gas ETFs On A Roll

Market Wrap For January 17: Stocks Finish Week With Mixed Results

Top Trending Tickers On StockTwits For January 17

Market Wrap For January 6: Busy Day For Analysts Upgrades and Downgrades

ARIAD Pharmaceuticals Recent News

Market Wrap For January 2: Markets Begin 2014 on Negative Note

Market Wrap For December 20: Markets Gain On GDP Data

Market Wrap For December 9: Investors Digest Further Clues Hinting at An Upcoming Taper

Market Wrap For November 25: Nasdaq Breaks 4,000 Level For First Time Since 2000

Market Wrap For November 22: Markets Finish The Week On a Positive Note

Three Biotech Stocks Analysts Are Keen On (ARIA, MACK, GEVA)

Best Biotech Stocks of 2011

J.P. Morgan Reiterates Overweight Rating On Ariad Pharmaceuticals

JP Morgan Raises PT On Ariad Pharmaceuticals To $13

Jefferies Provides Color on Ariad Pharmaceuticals, Buy

Brean Murray Raises PT on Aria Pharmaceuticals To $11

Ariad Pharmaceuticals Announces Its Phase 3 SUCCEED Trial Hits Primary Endpoint

Jefferies Raises PT On Ariad Pharmaceuticals

Ponatinib, A Key Driver For ARIAD Pharmaceuticals, Jefferies Reports